找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Data Monitoring in Clinical Trials; A Case Studies Appro David L. DeMets,Curt D. Furberg,Lawrence M. Friedm Book 2006 Springer-Verlag New Y

[復(fù)制鏈接]
樓主: hexagon
31#
發(fā)表于 2025-3-27 00:57:52 | 只看該作者
The Essentials of Nursing Management Seriesomparing candesartan with placebo in patients with chronic heart failure (CHF) who (1) were intolerant to angiotensin converting enzyme (ACE)-inhibitor and had left ventricular ejection fraction (LVEF) ≤ 40%, (2)) were on ACE-inhibitor and had LVEF ≤ 40% or (3)) had LVEF > 40%. CHARM provides an int
32#
發(fā)表于 2025-3-27 04:04:50 | 只看該作者
The Essentials of Nursing Management Seriesmplex process. It may involve, among other things, the need to (1) determine whether the observed treatment differences are likely to represent real effects and are not due to chance; (2) weigh the importance of different response variables, some possibly trending in favor of the treatment and some
33#
發(fā)表于 2025-3-27 08:06:37 | 只看該作者
The Patient-Surgeon Relationships with a recent myocardial infarction would reduce the incidence of sudden death and total mortality, using three drugs known to suppress cardiac arrhythmias. Patients were randomized to receive either active drug or a matching placebo. The trial was terminated after only 15% of the planned-for even
34#
發(fā)表于 2025-3-27 10:48:31 | 只看該作者
Communication with Young Peoplestudies with milrinone, a cyclic AMP-enhancing positive inotropic agent. Earlier studies had shown positive effects of milrinone on cardiac function and exercise performance in patients with chronic heart failure. To determine the effect of milrinone on mortality, patients with severe chronic heart
35#
發(fā)表于 2025-3-27 14:22:27 | 只看該作者
36#
發(fā)表于 2025-3-27 21:09:37 | 只看該作者
37#
發(fā)表于 2025-3-27 21:58:32 | 只看該作者
38#
發(fā)表于 2025-3-28 02:15:53 | 只看該作者
The Patient-Surgeon Relationshipythmias. Patients were randomized to receive either active drug or a matching placebo. The trial was terminated after only 15% of the planned-for events had been observed with an unexpected but dramatic increase in sudden death and total mortality in those patients receiving two of the active therapies. Later, the third drug was also discontinued.
39#
發(fā)表于 2025-3-28 10:04:55 | 只看該作者
40#
發(fā)表于 2025-3-28 13:23:52 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-30 22:44
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
洛阳市| 洛扎县| 遂平县| 子长县| 西吉县| 鹤壁市| 天峨县| 岳阳市| 乐陵市| 左权县| 景德镇市| 红原县| 都兰县| 高唐县| 颍上县| 锦州市| 新邵县| 新绛县| 贵南县| 辽源市| 高碑店市| 油尖旺区| 进贤县| 天镇县| 洱源县| 雷州市| 开江县| 察哈| 苏州市| 沁源县| 明水县| 忻州市| 青铜峡市| 南城县| 石河子市| 满城县| 台前县| 芜湖市| 广饶县| 蒙自县| 毕节市|